Local Paclitaxel Delivery for SFA Disease
| Status: | Archived |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | January 2009 |
| End Date: | June 2012 |
Treatment of Superficial Femoral Artery Atherosclerotic Disease With Local Delivery of Paclitaxel Using an Irrigating Catheter: a Randomized, Single-center Pilot Study
To see if restenosis rates of superficial femoral artery atherosclerosis with percutaneous
techniques can be improved using paclitaxel.
Treatment of superficial femoral artery atherosclerosis with percutaneous techniques is
hindered by high restenosis rates. Paclitaxel inhibits restenosis in coronary arteries, and
a few studies suggest it may be effective in reducing restenosis rates in peripheral
arteries. The investigators hypothesize that delivering paclitaxel through an irrigating
catheter will be superior in preventing restenosis.
We found this trial at
1
site
Click here to add this to my saved trials
